Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis

Transplantation Proceedings

Volumn 42, Issue 7, 2010, Pages 2634-2641

  Weigand, K ^a   Schnitzler, P ^a   Schmidt, J ^a   Chahoud, F ^a   Gotthardt, D ^a   Schemmer, P ^a   Stremmel, W ^a   Sauer, P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION;

ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TISSUE DONORS; VIRAL MATRIX PROTEINS;

EID: 77956475598     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.04.025     Document Type: Article

References (38)

1. R.H. Rubin Infectious disease complications of renal transplantation Kidney Int 44 1993 221
2. D.J. Winston, C. Emmanouilides, and R.W. Busuttil Infections in liver transplant recipients Clin Infect Dis 21 1995 1077
3. E.A. Dominguez Long-term infectious complications of liver transplantation Semin Liver Dis 15 1995 133
4. E. Farrugia, and T.R. Schwab Management and prevention of cytomegalovirus infection after renal transplantation Mayo Clin Proc 67 1992 879
5. J.K. Preiksaitis, D.C. Brennan, and J. Fishman Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report Am J Transplant 5 2005 218
6. M.A. Schnitzler, J.A. Lowell, and K.L. Hardinger The association of cytomegalovirus seropairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral gangciclovir CMV prophylaxis Am J Transplant 3 2003 445
7. J.G. O'Grady, J.G. Alexander, and S. Sutherland Cytomegalovirus infection and donor/recipient HLA antigen: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation Lancet 2 1988 302
8. J.A. Khoury, G.A. Storch, and D.L. Bohl Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients Am J Transplant 6 2006 2134
9. M. Buchler, L. Hurault de, and C. Madec Induction therapy by antithymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy Clin Transplant 17 2003 539
10. G.W. Burke, D.B. Kaufmann, and J.M. Millis Transplantation 77 2004 1269
11. D.J. Winston, D. Wirin, and A. Shaked Randomised comparison of ganciclovir and high- dose acyclovir for long-term cytomegalovirus infection in liver-transplant recipients Lancet 346 1995 69
12. M.A. Schnitzler, J.A. Lowell, and S.P. Hmiel Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching J Am Soc Nephrol 14 2003 780
13. C.V. Paya, A. Human, and E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611
14. R.J. Stratta, M.S. Shaefer, and R.S. Markin Clinical patterns of cytomegalovirus disease after liver transplantation Arch Surg 124 1989 1443
15. N. Singh, J.S. Dummer, and S. Kusne Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies J Infect Dis 158 1988 124
16. R.B. Freeman, C.V. Paya, and M.D. Pescovitz Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients Transplantation 78 2004 1765
17. R.R. Razonable, A. Rivero, and A. Rodriguez Allograft rejection predicts the occurrence of late- onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir J Infect Dis 184 2001 1461
18. A.T. Song, E. Abdala, and P.R. Bonazzi Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients? A mini-review Braz J Infect Dis 10 2006 132
19. F. Moreso, D. Seron, and J.M. Morales Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses Clin Transplant 12 1998 198
20. E.M. Hodson, C.A. Jones, and A.V. Webster Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials Lancet 365 2005 2105
21. A. Asberg, A. Humar, and H. Rollag Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disaese in solid organ transplant recipients Am J Transplant 7 2007 2106
22. T. Reischig, P. Jindra, and O. Hes Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation Am J Transplant 8 2008 69
23. J. Levitsky, N. Singh, and M.M. Wagener A survey of CMV prevention strategies after liver transplantation Am J Transplant 8 2008 158
24. D.C. Brennan, K.A. Garlock, and G.G. Singer Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients Transplantation 64 1997 1843
25. S.K. Arthurs, A.J. Eid, and R.A. Pedersen Delayed-onset primary cytomegalovirus disease after liver transplantation Liver Transpl 13 2007 1703
26. A.P. Limaye, R. Bakthavatsalam, and H.W. Kim Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis Transplantation 81 2006 1645
27. M.F. Mangano, R.L. Hodinka, and J.G. Spivack Detection of human cytomegalovirus by polymerase chain reaction Y. Becker, G. Darai, Diagnosis of human viruses by polymerase chain reaction technology 1992 Springer New York
28. M.L. Landry, and D. Ferguson Comparison of quantitative cytomegalovirus antigenemia assay with culture and correlation with clinical disease J Clin Microbiol 31 1993 2851
29. N. Singh, D.L. Paterson, and T. Gayowski Cytomegalovirus antigenemia directed preemptive prophylaxis with oral versus i.v. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial Transplantation 70 2000 717
30. R.R. Razonable, Hv.H. Cruijsen, and R.A. Brown Dynamics of cytomegalovirus replication during preemptive therapywith oral ganciclovir J Infect Dis 187 2003 1801
31. A.C. Allison, and E.M. Eugui Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 15 2005 S181
32. M. Giral, J.M. Nguyen, and P. Daguin Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction J Am Soc Nephrol 12 2001 1758
33. C. Moench, A.P. Barreiros, and M. Schuchmann Tacrolimus monotherapy without steroids after liver transplantation: a prospective randomized double-blinded placebo-controlled trial Am J Transplant 7 2007 1616
34. J.D. Eason, G.E. Loss, and J. Blazek Steroid-free liver transplantation using rabbit antithymocyte globuline induction: results of a prospective randomized trial Liver Transpl 7 2001 693
35. K.W. Burak, W.K. Kremers, and K.P. Batts Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C Liver Transpl 8 2002 362
36. C. La Rosa, A. Krishnan, and J. Longmate Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease J Infect Dis 197 2008 25
37. A.P. Limaye, R. Bakthavatsalam, and H.W. Kim Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis Transplantation 78 2004 1390
38. D. Hughes, J. Hafferty, and L. Fulton Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients J Clin Virol 41 2008 92